Claudin-6 Antibody (IM-301) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28245IR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Chicken
Applications
ELISA, Flow Cytometry, Functional
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Human IgG Clone # IM-301
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Claudin-6 Antibody (IM-301) [DyLight 755]
Immunogen
CLDN6
Clonality
Monoclonal
Host
Human
Isotype
IgG
Applications for Claudin-6 Antibody (IM-301) [DyLight 755]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Claudin-6
Alternate Names
Claudin6, CLDN6, Skullin 2
Gene Symbol
CLDN6
Additional Claudin-6 Products
Product Documents for Claudin-6 Antibody (IM-301) [DyLight 755]
Product Specific Notices for Claudin-6 Antibody (IM-301) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...